249 Etiology of Diabetic Ketoacidosis in Medication Adherent versus Medication Non-Adherent Patients in the Emergency Department SettingTo validate risk scores to predict occurrence of type 2 diabetes in the Dutch population. Prospective cohort study. Twelve basic risk scores and 13 extensive risk scores...
Case example: A 7-year-old child with new-onset diabetes was admitted to a medical facility for diabetic ketoacidosis. An IV was started in her hand for the administration of fluids (IV saline) to treat dehydration. During the rehydration process, the patient developed puffy eyelids, elevated ...
Douros, A. et al. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis : a multicenter cohort study.Ann. Intern. Med.173, 417–425 (2020). ArticlePubMedGoogle Scholar Fu, E. L. Target trial emulation to improve causal inference from observational data: what, why,...
Diabetic ketoacidosis is an all too frequent and sometimes preventable complication of Type I diabetes mellitus, responsible for significant morbidity and ... NH White - 《Reviews in Endocrine & Metabolic Disorders》 被引量: 53发表: 2003年 Thalidomide: An Old Drug with New Clinical Applications Per...
TRIJARDY XR is not for use to lower blood sugar in people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in the blood or urine). If you have had pancreatitis (inflammation of the pancreas) in the past, it is not known if you have a higher...
AVANDIA does not cause your body to make more insulin.10711072 AVANDIA is not for people with type 1 diabetes mellitus or to treat a condition1073 called diabetic ketoacidosis.10741075 It is not known if AVANDIA is safe and effective in children under 18 years old.10761077 Who should not take...
STEGLATRO is a prescription pill used in adults with type 2 diabetes to improve blood sugar (glucose) control along with diet and exercise. STEGLATRO is not for people with type 1 diabetes. It may increase the risk of diabetic ketoacidosis in these people. ...
The overall safety profile of Jardiance®was consistent with previous trials. The incidence of diabetic ketoacidosis was at or below 0.1 percent and similar across all treatment groups. These data were presented today at the 51stEuropean Association for the Study of Diabetes Annual Meeting in Stock...
The overall safety profile of Jardiance® was consistent with previous trials. The incidence of diabetic ketoacidosis was at or below 0.1 percent and similar across all treatment groups. These data were presented today at the 51st European Association for the Study of Diabetes Annual Meeting in ...
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT -2 Inhibitors and Diabetic Ketoacidosis. Endocr Pract. 2016;22(6):753 -762. 3. American Association of Clinical Endocrinologists. (2015). American ...